MTOR and neoplasm: In this study, we proposed a therapeutic strategy of targeting mTOR for remodeling the tumor metabolism and TIME via a BBB-penetrating liposomal system for codelivery of honokiol (HNK) and disulfiram/copper (DSF/Cu) complex.